Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Jayamas Medica Industri Tbk. (OMED) vs Solusi Bangun Indonesia Tbk. (SMCB)

Jayamas Medica Industri Tbk.Trading
Solusi Bangun Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Jayamas Medica Industri Tbk. dan Solusi Bangun Indonesia Tbk.: Jayamas Medica Industri Tbk. diperdagangkan di Rp214 (kapitalisasi pasar 5,79 T, volume 24 jam 9,53 jt), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

OMEDSMCB
Kapitalisasi Pasar
5,79 T6,99 T
Volume
9,53 jt
Lot
95,3 rb
Perputaran
2,05 M
Harga Rata-rata
215,03
Nilai Transaksi
2,05 M
Harga Ekuilibrium Indikatif
214
Volume Ekuilibrium Indikatif
1,69 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

OMED
Lihat detail
SMCB
Lihat detail

Tentang Jayamas Medica Industri Tbk.

PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.

Selengkapnya di halaman OMED

Tentang Solusi Bangun Indonesia Tbk.

PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.

Selengkapnya di halaman SMCB